The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Esophageal toxicity
Publications
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2016 Mar;118;465-70 — 2016 Mar — 465-70
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
International journal of radiation oncology, biology, physics 2014 Sep 01;90;197-202 — 2014 Sep 01 — 197-202
Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer.
Lung India : official organ of Indian Chest Society 2014 Apr;31;158-60 — 2014 Apr — 158-60
Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, Barriger RB, Moreno-Jiménez M, Kim TH, Ramella S, Everitt S, Rengan R, Marks LB, De Ruyck K, Warner A, Rodrigues G
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.
International journal of radiation oncology, biology, physics 2013 Nov 15;87;690-6 — 2013 Nov 15 — 690-6